首页> 外文学位 >Hepatoma plasma membrane and serum proteins
【24h】

Hepatoma plasma membrane and serum proteins

机译:肝癌质膜和血清蛋白

获取原文
获取原文并翻译 | 示例

摘要

The serum of tumour-bearing rats has been tested to determine if there is any protein shedding from the plasma membrane of the tumour cells. Both immunological and enzymological approaches have been employed. Methods for isolation of plasma membrane fragments for two different hepatomas have been developed. Plasma membrane fragments from the less rapidly growing (WDA) hepatoma are recovered in two distinct size classes which, it is suggested, derive from two distinct areas of the plasma membrane which have been distinguished by electron microscopy. Plasma membranes from the more rapidly growing (UA) hepatoma appeared much more uniform both in morphological appearance and in cell fractionation experiments. An antiserum has been prepared against purified plasma membrane fragments from the 'UA' hepatoma. The reaction of this antiserum has been examined by crossed immunoelectrophoresis and the various proteins characterised by comparison with the reaction of the sera with anti-(rat serum) and antiserum prepared against the serum of tumour-bearing rats and normal liver plasma membrane. The results did not show extensive release of material from the tumour plasma membrane into the serum, although evidence was obtained for a complex containing material deriving from tumour plasma membrane together with host serum proteins. Enzymological methods have been used to study the 5'-nucleotidase and alkaline phosphatase enzymes in plasma membrane fragments and in serum. Evidence was obtained that the apparent 5'-nucleotidase activity of normal rat serum is largely due to a non-specific phosphatase. This was also suggested by gel filtration of serum on Sephadex G-200. Gel filtration of the serum of tumour-bearing rats did, however, give evidence for the presence of a very; high molecular weight complex which contains 5'-nucleotidase but with little if any alkaline phosphatase activity. This would be consistent with the complex deriving from the surface of tumour cells.
机译:已经测试了荷瘤大鼠的血清,以确定是否有任何蛋白质从肿瘤细胞的质膜脱落。免疫和酶学方法都已被采用。已经开发出用于分离两种不同肝癌的质膜片段的方法。从生长较慢的(WDA)肝癌中获得的质膜碎片被分为两个不同的大小类别,这建议是从质膜的两个不同区域中获得的,这两个区域已通过电子显微镜进行了区分。在形态学外观和细胞分离实验中,来自生长较快的(UA)肝癌的质膜均表现得更加均匀。已经针对来自“ UA”肝癌的纯化质膜片段制备了抗血清。该抗血清的反应已通过交叉免疫电泳和各种蛋白质进行了检验,其特征在于将血清与抗荷瘤大鼠血清和针对荷瘤大鼠血清和正常肝细胞膜制备的抗血清的反应进行比较。尽管没有证据表明复合物含有从肿瘤质膜衍生的物质以及宿主血清蛋白,但结果并未显示出从肿瘤质膜向血清中的大量释放。酶学方法已用于研究质膜片段和血清中的5'-核苷酸酶和碱性磷酸酶。已获得证据,正常大鼠血清的表观5'-核苷酸酶活性很大程度上是由于非特异性磷酸酶所致。在Sephadex G-200上对血清进行凝胶过滤也表明了这一点。但是,荷瘤大鼠血清的凝胶过滤确实提供了一个非常有证据的证据。含有5'-核苷酸酶但几乎没有碱性磷酸酶活性的高分子量复合物。这将与源自肿瘤细胞表面的复合物一致。

著录项

  • 作者单位

    University of Surrey (United Kingdom).;

  • 授予单位 University of Surrey (United Kingdom).;
  • 学科 Medicine.
  • 学位 M.Phil.
  • 年度 1979
  • 页码 159 p.
  • 总页数 159
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号